LifeStance Health reports Q2 2026 revenue up over 26% to $435 million

LifeStance Health Group reported a strong second quarter with revenue growth of over 26% to $435 million and adjusted EBITDA margins exceeding 15%, per its Q2 2026 earnings conference call transcript.

Detected & updated continuously · Source: Nebula